Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02355093Phase 4Unknown
Phase 4, randomised trial of ropivacaine in pain (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: quadriceps muscle strength at 3 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02355093.